Meningitis Diagnostic Testing Market, By Test Type (Latex Agglutination Tests, PCR Assay, Lateral-Flow Assay, CRISPR-based Assay, Culture Test, and ELISA Tests), By Technology, By Sample Type, By Pathogen, By End-User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV5384
|
Published Date
June 2026
|
Pages
416
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Meningitis Diagnostic Testing Market size was valued at US$ 128.98 Million in 2025, expanding at a CAGR of 3.5% from 2026 to 2033.
Meningitis diagnostic testing refers to a range of medical examinations used to determine whether an individual is infected with meningitis, a condition characterized by inflammation of the meninges—the protective membranes surrounding the brain and spinal cord. These tests are also designed to identify the underlying causative agents, enabling healthcare providers to select the most effective treatment approach for the patient. Common diagnostic procedures include cerebrospinal fluid (CSF) analysis, blood cultures, polymerase chain reaction (PCR) testing, antigen detection tests, microscopic examination, and other advanced molecular diagnostic techniques. The primary objective of these investigations is to ensure accurate and timely diagnosis, allowing for early medical intervention and reducing the risk of severe complications.
According to global health data from international public health organizations, meningitis continues to contribute significantly to infectious disease burden worldwide, particularly in regions with limited healthcare access. As a result, meningitis diagnostic testing has become an essential component of modern healthcare systems globally, supporting improved disease detection, monitoring, and patient outcomes.
Meningitis Diagnostic Testing Market- Market Dynamics
Growth Driven by Advancements in Nanotechnology and Microfabrication
The increasing number of meningitis cases worldwide is a key factor driving the growth of the meningitis diagnostic testing market, as early and accurate diagnosis is essential for effective treatment and improved patient outcomes. Meningitis remains a major global health concern due to its high mortality and morbidity rates, as well as the risk of long-term complications such as brain damage and neurological impairments.
According to the World Health Organization (WHO), meningitis continues to pose a serious public health challenge across the globe, particularly in low-income countries and the African meningitis belt, where outbreaks are more frequent. Global health estimates indicate that around 2.5 million people are affected by meningitis each year, including approximately 1.6 million cases of bacterial meningitis, resulting in nearly 240,000 deaths annually. In addition, about 20% of survivors experience long-term disabilities, including hearing loss, memory impairment, and other neurological complications. In response to this ongoing burden, WHO has introduced a global roadmap aimed at defeating meningitis by 2030 through prevention, diagnosis, and improved treatment strategies.
Meningitis Diagnostic Testing Market- Segmentation Analysis:
The Global Meningitis Diagnostic Testing Market is segmented on the basis of Test Type, Technology, Sample Type, Pathogen, End-User, and Region.
The meningitis diagnostic testing market is segmented by test type into latex agglutination tests, PCR assays, lateral-flow assays, CRISPR-based assays, culture tests, and ELISA tests, with PCR assays expected to dominate the market. This dominance is mainly due to their ability to deliver rapid, highly sensitive, and accurate detection of pathogens responsible for meningitis. PCR-based techniques can identify bacterial, viral, or fungal genetic material present in cerebrospinal fluid (CSF) or other clinical samples, enabling precise pathogen detection even at very early stages of infection. The increasing need for quick and reliable diagnostic methods is especially critical in severe cases where delayed treatment can lead to life-threatening outcomes. According to global public health data from international health organizations, infectious diseases remain a major cause of mortality worldwide, with early diagnosis playing a crucial role in reducing disease burden and improving survival rates, thereby strengthening the adoption of advanced molecular diagnostic technologies such as PCR assays.
Based on pathogen type, the market is segmented into bacterial, fungal, parasitic, and viral meningitis, with bacterial meningitis accounting for the largest share. This is primarily due to its severe clinical impact and the urgent need for accurate and rapid diagnostic testing. Bacterial meningitis is associated with high mortality and morbidity rates and can lead to serious long-term complications such as hearing loss, brain damage, and cognitive impairments if not diagnosed and treated promptly. The increasing prevalence of bacterial infections caused by pathogens such as Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae is further driving the demand for advanced diagnostic solutions. As per global health statistics from international disease control agencies, bacterial infections continue to represent a significant share of meningitis cases worldwide, particularly in vulnerable populations, reinforcing the need for improved diagnostic technologies to enable early detection and effective clinical management.
Meningitis Diagnostic Testing Market- Geographical Insights
North America is expected to lead the meningitis diagnostic testing market, driven by its advanced healthcare infrastructure, widespread adoption of molecular diagnostic technologies, and strong focus on infectious disease surveillance. The region benefits from well-established healthcare networks, highly developed clinical laboratories, and significant investment in research and development, all of which support accurate and timely diagnosis and management of meningitis cases. Rising awareness among healthcare professionals regarding the importance of early diagnosis, combined with the availability of advanced testing methods such as polymerase chain reaction (PCR) assays, multiplex molecular diagnostic panels, and automated laboratory systems, is further increasing the volume of diagnostic testing across the region. According to global public health data from international health agencies, high-income regions consistently demonstrate stronger diagnostic capacity and earlier disease detection rates, contributing to better patient outcomes in infectious diseases like meningitis.
In addition, public health organizations such as the Centers for Disease Control and Prevention (CDC) in the United States and the Public Health Agency of Canada (PHAC) actively monitor meningitis cases, support vaccination programs, and strengthen disease surveillance systems. These initiatives have significantly improved early detection and reporting mechanisms, thereby driving sustained demand for advanced meningitis diagnostic testing solutions across North America.
US Meningitis Diagnostic Testing Market- Country Insights
In North America, the United States is expected to account for the largest share of the meningitis diagnostic testing market. Growth in the country is strongly supported by continuous advancements in medical technology and the widespread availability of advanced diagnostic solutions. The adoption of high-precision techniques such as PCR-based testing has significantly improved the speed and accuracy of meningitis detection, enabling healthcare professionals to identify causative pathogens more efficiently than traditional methods.
In addition, increased public awareness regarding meningitis symptoms and the importance of early diagnosis has encouraged more individuals to seek timely medical attention, further driving demand for diagnostic testing services. According to global public health data from international health organizations, infectious diseases continue to place a substantial burden on healthcare systems worldwide, with early and accurate diagnosis playing a critical role in reducing complications and mortality rates. This global emphasis on improved disease detection and surveillance is further strengthening the adoption of advanced meningitis diagnostic technologies across the United States.
Meningitis Diagnostic Testing Market- Competitive Landscape:
The meningitis diagnostic testing market is highly competitive, involving global diagnostic service providers, molecular diagnostic technology manufacturers, clinical laboratory solution companies, and biotechnology firms. Competition in this space is primarily driven by technological innovation, diagnostic accuracy, test turnaround time, portfolio breadth, regulatory approvals, and global distribution capabilities. Market participants are increasingly focused on developing advanced molecular diagnostic platforms, multiplex PCR assays, rapid antigen detection kits, and automated laboratory systems that enable faster and more precise identification of pathogens responsible for meningitis. Rising demand for rapid and reliable diagnosis is also encouraging higher investment in research and development across the industry. According to global health technology reports from international medical organizations, the increasing burden of infectious diseases worldwide is accelerating the need for more efficient diagnostic solutions, further intensifying competition among key market players.
Recent Developments
- In February 2024, QIAGEN introduced two new syndromic testing panels for its QIAstat-Dx platform in India, including the Gastrointestinal Panel 2 and the Meningitis/Encephalitis Panel. These additions complement the previously authorized Respiratory SARS-CoV-2 Panel and have received regulatory approval from the Central Drugs Standard Control Organization (CDSCO). This development enables faster, more accurate, and simplified diagnosis of infectious diseases, supporting improved clinical decision-making and patient care.
- In September 2024, Thermo Fisher Scientific expanded its bioanalytical laboratory services network in Europe to meet the growing demand for advanced testing solutions across pharmaceuticals and biotechnology sectors. The expansion includes enhanced laboratory capacity and the integration of advanced technologies aimed at improving testing efficiency and reducing turnaround times. This strategic move strengthens the company’s ability to support increasing global demand for high-precision diagnostic and analytical services.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- QIAGEN N.V.
- BD
- Hologic Inc.
- Bio-Rad Laboratories
- Seegene Inc.
- ELITechGroup
- F. Hoffmann-La Roche Ltd.
- GenMark Diagnostics
- bioMérieux
- IMMY
- DiaSorin S.p.A.
- Oxford Nanopore Technologies
- Abbott
- Danaher
- Siemens Healthineers
- Thermo Fisher Scientific
- Trinity Biotech
- Tosoh Corporation
- Meridian Bioscience
- Quanterix Corporation
- Others
GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2020 - 2033
- Latex Agglutination Tests
- PCR Assay
- Lateral-Flow Assay
- CRISPR-based Assay
- Culture Test
- ELISA Tests
GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Molecular Diagnostics
- Microbiology/Culture
- Immunoassays
- Next-Generation Sequencing
GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2020 - 2033
- Cerebrospinal Fluid (CSF)
- Nasopharyngeal Swab
- Blood/Serum
- Others
GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET, BY PATHOGEN- MARKET ANALYSIS, 2020 - 2033
- Bacterial
- Fungal
- Parasitic
- Viral
GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals
- Academic & Research Labs
- Diagnostic Centers
- Others
GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Meningitis Diagnostic Testing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Meningitis Diagnostic Testing Market Snippet by Test Type
2.1.2. Meningitis Diagnostic Testing Market Snippet by Technology
2.1.3. Meningitis Diagnostic Testing Market Snippet by Sample Type
2.1.4. Meningitis Diagnostic Testing Market Snippet by Pathogen
2.1.5. Meningitis Diagnostic Testing Market Snippet by End-User
2.1.6. Meningitis Diagnostic Testing Market Snippet by Country
2.1.7. Meningitis Diagnostic Testing Market Snippet by Region
2.2. Competitive Insights
3. Meningitis Diagnostic Testing Key Market Trends
3.1. Meningitis Diagnostic Testing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Meningitis Diagnostic Testing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Meningitis Diagnostic Testing Market Opportunities
3.4. Meningitis Diagnostic Testing Market Future Trends
4. Meningitis Diagnostic Testing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Meningitis Diagnostic Testing Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Meningitis Diagnostic Testing Market Landscape
6.1. Meningitis Diagnostic Testing Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Meningitis Diagnostic Testing Market – By Test Type
7.1. Overview
7.1.1. Segment Share Analysis, By Test Type, 2025 & 2033 (%)
7.1.2. Latex Agglutination Tests
7.1.3. PCR Assay
7.1.4. Lateral-Flow Assay
7.1.5. CRISPR-based Assay
7.1.6. Culture Test
7.1.7. ELISA Tests
8. Meningitis Diagnostic Testing Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
8.1.2. Molecular Diagnostics
8.1.3. Microbiology/Culture
8.1.4. Immunoassays
8.1.5. Next-Generation Sequencing
9. Meningitis Diagnostic Testing Market – By Sample Type
9.1. Overview
9.1.1. Segment Share Analysis, By Sample Type, 2025 & 2033 (%)
9.1.2. Cerebrospinal Fluid (CSF)
9.1.3. Nasopharyngeal Swab
9.1.4. Blood/Serum
9.1.5. Others
10. Meningitis Diagnostic Testing Market – By Pathogen
10.1. Overview
10.1.1. Segment Share Analysis, By Pathogen, 2025 & 2033 (%)
10.1.2. Bacterial
10.1.3. Fungal
10.1.4. Parasitic
10.1.5. Viral
11. Meningitis Diagnostic Testing Market – By End-User
11.1. Overview
11.1.1. Segment Share Analysis, By End-User, 2025 & 2033 (%)
11.1.2. Hospitals
11.1.3. Academic & Research Labs
11.1.4. Diagnostic Centers
11.1.5. Others
12. Meningitis Diagnostic Testing Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
12.2.1. Overview
12.2.2. Meningitis Diagnostic Testing Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.2.4. North America Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.2.5. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.6. North America Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.2.7. North America Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.2.8. North America Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Meningitis Diagnostic Testing Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Meningitis Diagnostic Testing Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Meningitis Diagnostic Testing Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.5.8. LATAM Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Meningitis Diagnostic Testing Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Test Type, 2020 - 2033 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Pathogen, 2020 - 2033 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End-User, 2020 - 2033 (US$ Million)
13. Key Vendor Analysis- Meningitis Diagnostic Testing Industry
13.1. Competitive Benchmarking
13.1.1. Competitive Dashboard
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. QIAGEN N.V.
13.2.2. BD
13.2.3. Hologic Inc.
13.2.4. Bio-Rad Laboratories
13.2.5. Seegene Inc.
13.2.6. ELITechGroup
13.2.7. F. Hoffmann-La Roche Ltd.
13.2.8. GenMark Diagnostics
13.2.9. bioMérieux
13.2.10. IMMY
13.2.11. DiaSorin S.p.A.
13.2.12. Oxford Nanopore Technologies
13.2.13. Abbott
13.2.14. Danaher
13.2.15. Siemens Healthineers
13.2.16. Thermo Fisher Scientific
13.2.17. Trinity Biotech
13.2.18. Tosoh Corporation
13.2.19. Meridian Bioscience
13.2.20. Quanterix Corporation
13.2.21. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- QIAGEN N.V.
- BD
- Hologic Inc.
- Bio-Rad Laboratories
- Seegene Inc.
- ELITechGroup
- F. Hoffmann-La Roche Ltd.
- GenMark Diagnostics
- bioMérieux
- IMMY
- DiaSorin S.p.A.
- Oxford Nanopore Technologies
- Abbott
- Danaher
- Siemens Healthineers
- Thermo Fisher Scientific
- Trinity Biotech
- Tosoh Corporation
- Meridian Bioscience
- Quanterix Corporation
- Others
GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2020 - 2033
- Latex Agglutination Tests
- PCR Assay
- Lateral-Flow Assay
- CRISPR-based Assay
- Culture Test
- ELISA Tests
GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Molecular Diagnostics
- Microbiology/Culture
- Immunoassays
- Next-Generation Sequencing
GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2020 - 2033
- Cerebrospinal Fluid (CSF)
- Nasopharyngeal Swab
- Blood/Serum
- Others
GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET, BY PATHOGEN- MARKET ANALYSIS, 2020 - 2033
- Bacterial
- Fungal
- Parasitic
- Viral
GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals
- Academic & Research Labs
- Diagnostic Centers
- Others
GLOBAL MENINGITIS DIAGNOSTIC TESTING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
